OC-007
/ Adlego, Karolinska Institute
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
March 27, 2024
OpenCorona1: A Randomized, Phase I Study of DNA Vaccine OC-007 as a Booster Dose of COVID-19 Vaccine
(clinicaltrials.gov)
- P1 | N=16 | Completed | Sponsor: Matti Sällberg | Recruiting ➔ Completed
Trial completion • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
February 17, 2023
OpenCorona1: A Randomized, Phase I Study of DNA Vaccine OC-007 as a Booster Dose of COVID-19 Vaccine
(clinicaltrials.gov)
- P1 | N=16 | Recruiting | Sponsor: Matti Sällberg | Not yet recruiting ➔ Recruiting
Enrollment open • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
January 17, 2023
OpenCorona1: A Randomized, Phase I Study of DNA Vaccine OC-007 as a Booster Dose of COVID-19 Vaccine
(clinicaltrials.gov)
- P1 | N=16 | Not yet recruiting | Sponsor: Matti Sällberg
New P1 trial • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
1 to 3
Of
3
Go to page
1